Home > IVD Products > ImmunoAssays > Infectious Diseases > Hepatitis A (HAV) > HAV, Anti-HAV IgM, ELISA, 96 tests < you are here

HAV, Anti-HAV IgM, ELISA, 96 tests

Anti-HAV IgM ELISA is a fast test for the qualitative detection of IgM antibody to Hepatitis A virus in serum or plasma (heparin, citrate or EDTA) specimens. This is an enzyme linked immunosorbent assay (ELISA)which utilizes Anti-human IgM on microtiter wells as solid phase and HAV Ag and peroxidase-conjugated Anti-HAV in liquid phase in an “IgM capture” principle to detect Anti-HAV IgM levels in serum or plasma. Specimens with absorbance values greater than the Cutoff Value are considered REACTIVE for Anti-HAV IgM. Specimens with absorbance values less or equal than the Cutoff Value are considered NONREACTIVE for Anti-HAV IgM. The test has to be repeated in duplicate for specimens with absorbance value within the retest range (Cutoff Value ± 10 %) and interpreted as above. If the absorbance of any of the specimens retested in duplicate is still within the retest range, it is suggested to test follow-up samples of the patient.

Catalog # KAPG4AME3
Format ELISA
Label HRP
Size 96 tests
Sample Type Serum, Plasma
Sample Volume 100 µL
Controls 2 levels
Sensitivity 61.7U/mL
Incubation 60 min/30 min

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: RA@diasource.be.

Documents - Download
Download "Instructions for Use" KAPG4AME3.pdf
Download "Material Safety Data Sheet" MSKAPG4AME3.pdf
Download brochure "Hepatitis" CATE.pdf

DIAsource ImmunoAssays SA
BE 0457.934.723
Rue du Bosquet, 2 | 1348 Louvain-la-Neuve - Belgium
Tel +32 10 84 99 11 | Fax +32 10 84 99 90

CLOSING DAYS 2019 : 1/01-22/04-01&30/05-10/06-21/07-15/08-01&11/11-25/12

Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.